CATX Insider Trading

Insider Ownership Percentage: 3.52%
Insider Buying (Last 12 Months): $58,051,753.87
Insider Selling (Last 12 Months): $0.00

Perspective Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Perspective Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Perspective Therapeutics Share Price & Price History

Current Price: $3.02
Price Change: Price Decrease of -0.09 (-2.89%)
As of 02/14/2025 05:00 PM ET

This chart shows the closing price history over time for CATX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Perspective Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/4/2024Heidi HensonDirectorBuy25,975$3.85$100,003.7525,975View SEC Filing Icon  
12/4/2024Johan M SpoorCEOBuy8,000$3.77$30,160.0036,257View SEC Filing Icon  
11/25/2024Johan M SpoorCEOBuy14,500$3.78$54,810.00152,072View SEC Filing Icon  
11/25/2024Jonathan Robert HuntCFOBuy12,829$3.82$49,006.7848,800View SEC Filing Icon  
11/25/2024Robert F Williamson IIIDirectorBuy6,266$3.64$22,808.24430,058View SEC Filing Icon  
6/17/2024Jonathan Robert HuntCFOBuy1,800$9.81$17,658.0035,971View SEC Filing Icon  
6/14/2024Lori A WoodsDirectorBuy4,587$10.90$49,998.30159,985View SEC Filing Icon  
6/13/2024Johan M SpoorCEOBuy10,000$11.70$117,000.0013,757View SEC Filing Icon  
6/3/2024Lori A WoodsDirectorBuy3,424$14.60$49,990.40155,398View SEC Filing Icon  
5/31/2024Jonathan Robert HuntCFOBuy2,500$14.00$35,000.0034,171View SEC Filing Icon  
5/31/2024Robert F Williamson IIIDirectorBuy5,500$13.80$75,900.0042,379View SEC Filing Icon  
5/29/2024Robert F Williamson IIIDirectorBuy3,003$13.30$39,939.9036,879View SEC Filing Icon  
3/6/2024Lantheus Alpha Therapy, LlcMajor ShareholderBuy6,043,103$9.50$57,409,478.5011,677,339View SEC Filing Icon  
1/29/2024Robert F Williamson IIIDirectorBuy2,526$6.40$16,166.4021,155View SEC Filing Icon  
1/25/2024Robert F Williamson IIIDirectorBuy2,213$4.90$10,843.707,567View SEC Filing Icon  
1/24/2024Markus PuhlmannInsiderBuy28,000$5.00$140,000.00137,542View SEC Filing Icon  
12/21/2023Robert F Williamson IIIDirectorBuy366$3.30$1,207.80366View SEC Filing Icon  
12/18/2023Jonathan Robert HuntCFOBuy12,500$2.60$32,500.0031,671View SEC Filing Icon  
12/18/2023Markus PuhlmannInsiderBuy6,041$2.60$15,706.6069,542View SEC Filing Icon  
12/18/2023Robert F Williamson IIIDirectorBuy1,000$2.60$2,600.001,000View SEC Filing Icon  
12/15/2023Markus PuhlmannInsiderBuy13,500$2.70$36,450.0063,500View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Perspective Therapeutics (NYSE:CATX)

54.66% of Perspective Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CATX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Perspective Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC70,150$0.22M0.0%+19.6%0.104%Search for SEC Filing on Google Icon
2/17/2025Velan Capital Investment Management LP500,000$1.60M1.4%N/A0.740%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC196,208$0.63M0.0%N/A0.290%Search for SEC Filing on Google Icon
2/17/2025Wexford Capital LP20,000$64K0.0%N/A0.030%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP151,610$0.48M0.0%N/A0.224%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP650,351$2.08M0.0%N/A0.962%Search for SEC Filing on Google Icon
2/17/2025Sherbrooke Park Advisers LLC21,564$69K0.0%N/A0.032%Search for SEC Filing on Google Icon
2/17/2025Sphera Funds Management LTD.460,247$1.47M0.3%-21.9%0.681%Search for SEC Filing on Google Icon
2/17/2025Point72 Asset Management L.P.54,893$0.18M0.0%N/A0.081%Search for SEC Filing on Google Icon
2/17/2025ProShare Advisors LLC15,225$49K0.0%+49.1%0.023%Search for SEC Filing on Google Icon
2/17/2025Nuveen Asset Management LLC722,048$2.30M0.0%-13.0%1.068%Search for SEC Filing on Google Icon
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 123,243$0.39M0.0%+73.8%0.182%Search for SEC Filing on Google Icon
2/17/2025Octagon Capital Advisors LP2,304,752$7.35M1.2%+62.1%3.410%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC1,295,343$4.13M0.0%N/A1.916%Search for SEC Filing on Google Icon
2/17/2025Janus Henderson Group PLC17,839$57K0.0%-99.6%0.026%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG46,579$0.15M0.0%+76.0%0.069%Search for SEC Filing on Google Icon
2/17/2025DAFNA Capital Management LLC130,169$0.42M0.1%-43.5%0.193%Search for SEC Filing on Google Icon
2/17/2025Deerfield Management Company L.P. Series C2,938,754$9.38M0.2%+4.3%4.348%Search for SEC Filing on Google Icon
2/17/2025Corton Capital Inc.19,180$61K0.0%N/A0.028%Search for SEC Filing on Google Icon
2/17/2025Cubist Systematic Strategies LLC261,474$0.83M0.0%N/A0.387%Search for SEC Filing on Google Icon
2/17/2025Balyasny Asset Management L.P.130,914$0.42M0.0%N/A0.194%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE48,777$0.16M0.0%-72.0%0.072%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets51,094$0.16M0.0%+7.4%0.076%Search for SEC Filing on Google Icon
2/17/2025Ameriprise Financial Inc.17,326$55K0.0%-97.4%0.026%Search for SEC Filing on Google Icon
2/14/2025Mercer Global Advisors Inc. ADV16,088$51K0.0%N/A0.024%Search for SEC Filing on Google Icon
2/14/2025Freestone Grove Partners LP47,386$0.15M0.0%N/A0.070%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC168,500$0.54M0.0%-71.5%0.249%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp487,273$1.55M0.0%+2.8%0.721%Search for SEC Filing on Google Icon
2/14/2025Tudor Investment Corp ET AL28,577$91K0.0%N/A0.042%Search for SEC Filing on Google Icon
2/14/2025Aquatic Capital Management LLC32,718$0.10M0.0%N/A0.048%Search for SEC Filing on Google Icon
2/14/2025Virtus ETF Advisers LLC20,487$65K0.0%+157.9%0.030%Search for SEC Filing on Google Icon
2/14/2025Nebula Research & Development LLC21,850$70K0.0%+47.2%0.032%Search for SEC Filing on Google Icon
2/14/2025Rock Springs Capital Management LP444,383$1.42M0.1%+7.2%0.657%Search for SEC Filing on Google Icon
2/14/2025MetLife Investment Management LLC22,228$71K0.0%-28.7%0.033%Search for SEC Filing on Google Icon
2/14/2025Altium Capital Management LLC92,224$0.29M0.1%-68.2%0.136%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP807,172$2.58M0.0%-45.9%1.194%Search for SEC Filing on Google Icon
2/13/2025Affinity Asset Advisors LLC1,300,000$4.15M0.6%+160.0%1.923%Search for SEC Filing on Google Icon
2/13/2025Jump Financial LLC215,725$0.69M0.0%N/A0.319%Search for SEC Filing on Google Icon
2/13/2025Walleye Capital LLC475,792$1.52M0.0%+2,526.2%0.704%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd18,070$58K0.0%-51.6%0.027%Search for SEC Filing on Google Icon
2/13/2025Mariner LLC46,900$0.15M0.0%N/A0.069%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC94,879$0.30M0.0%-16.8%0.140%Search for SEC Filing on Google Icon
2/13/2025Legal & General Group Plc48,538$0.16M0.0%-13.5%0.072%Search for SEC Filing on Google Icon
2/13/2025Aristides Capital LLC58,700$0.19M0.0%N/A0.087%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN26,462$84K0.0%+45.7%0.039%Search for SEC Filing on Google Icon
2/12/2025National Bank of Canada FI11,000$35K0.0%+549,900.0%0.016%Search for SEC Filing on Google Icon
2/12/2025Arrowstreet Capital Limited Partnership36,752$0.12M0.0%-64.1%0.054%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.149,045$0.48M0.0%+498.3%0.221%Search for SEC Filing on Google Icon
2/11/2025KLP Kapitalforvaltning AS24,769$79K0.0%N/A0.037%Search for SEC Filing on Google Icon
2/10/2025Swiss National Bank86,260$0.28M0.0%-6.4%0.128%Search for SEC Filing on Google Icon
2/7/2025HighTower Advisors LLC178,111$0.57M0.0%+26.1%0.264%Search for SEC Filing on Google Icon
2/7/2025Citizens Financial Group Inc. RI50,000$0.16M0.0%N/A0.074%Search for SEC Filing on Google Icon
2/7/2025AMG National Trust Bank29,980$92K0.0%-19.7%0.044%Search for SEC Filing on Google Icon
2/6/2025Aigen Investment Management LP10,522$34K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.406,966$1.30M0.0%-6.1%0.602%Search for SEC Filing on Google Icon
2/4/2025Bank of New York Mellon Corp143,469$0.46M0.0%+3.4%0.212%Search for SEC Filing on Google Icon
2/4/2025Y Intercept Hong Kong Ltd10,263$33K0.0%N/A0.015%Search for SEC Filing on Google Icon
2/3/2025Nicholson Wealth Management Group LLC1,609,283$5.13M3.4%+0.4%2.381%Search for SEC Filing on Google Icon
1/30/2025WealthPlan Investment Management LLC401,049$1.28M0.1%+18.2%0.593%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers94,992$0.30M0.0%+4.5%0.141%Search for SEC Filing on Google Icon
1/30/2025Vontobel Holding Ltd.16,000$51K0.0%N/A0.024%Search for SEC Filing on Google Icon
1/23/2025Koa Wealth Management LLC25,975$83K0.1%N/A0.038%Search for SEC Filing on Google Icon
1/22/2025Wealth Effects LLC38,000$0.12M0.0%+186.8%0.056%Search for SEC Filing on Google Icon
1/17/2025SG Americas Securities LLC26,088$83K0.0%+41.3%0.039%Search for SEC Filing on Google Icon
1/16/2025Trueblood Wealth Management LLC22,236$71K0.0%+37.0%0.033%Search for SEC Filing on Google Icon
1/15/2025Taylor & Morgan Wealth Management LLC56,000$0.18M0.1%+86.7%0.083%Search for SEC Filing on Google Icon
12/26/2024JPMorgan Chase & Co.24,912$0.33M0.0%+24.1%0.037%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC114,075$1.52M0.0%+587.9%0.169%Search for SEC Filing on Google Icon
11/18/2024JDM Financial Group LLC3,500$47K0.0%-90.0%0.005%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,164,204$15.55M0.0%+12.5%1.722%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC114,075$1.52M0.0%+587.9%0.169%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd37,300$0.50M0.0%N/A0.055%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC25,256$0.34M0.0%-67.9%0.037%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.589,295$7.87M1.3%-25.1%0.872%Search for SEC Filing on Google Icon
11/15/2024State Street Corp2,190,239$29.24M0.0%+119.6%3.240%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC4,799,352$64.01M0.0%+8.0%7.101%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC138,350$1.85M0.6%+21.8%0.205%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC28,723$0.38M0.0%N/A0.043%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC18,117$0.24M0.0%-96.5%0.027%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC58,678$0.78M0.0%+5.8%0.087%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank11,378$0.15M0.0%N/A0.017%Search for SEC Filing on Google Icon
11/14/2024Ally Bridge Group NY LLC341,739$4.56M2.4%-13.8%0.507%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC31,165$0.42M0.0%+159.1%0.046%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets47,565$0.64M0.0%+1,302.7%0.071%Search for SEC Filing on Google Icon
11/13/2024FMR LLC5,504,822$73.49M0.0%+3,994.9%8.164%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company20,514$0.27M0.0%+8.9%0.030%Search for SEC Filing on Google Icon
11/12/2024Eagle Asset Management Inc.181,467$2.42M0.0%-24.9%0.269%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.433,522$5.79M0.0%+221.7%0.643%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC10,289$0.14M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/7/2024LMR Partners LLP30,000$0.40M0.0%N/A0.044%Search for SEC Filing on Google Icon
11/6/2024RIA Advisory Group LLC25,620$0.34M0.1%N/A0.038%Search for SEC Filing on Google Icon
11/6/2024CIBC Asset Management Inc19,415$0.26M0.0%N/A0.029%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.50,460$0.67M0.0%+328.7%0.075%Search for SEC Filing on Google Icon
11/5/2024WealthPlan Investment Management LLC339,292$4.53M0.5%N/A0.503%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC11,424$0.15M0.0%N/A0.017%Search for SEC Filing on Google Icon
10/30/2024AlphaCentric Advisors LLC80,000$1.07M0.8%-2.4%0.128%Search for SEC Filing on Google Icon
10/28/2024Hills Bank & Trust Co1,027,830$13.72M1.0%N/A1.651%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE6,576$88K0.0%+142.7%0.011%Search for SEC Filing on Google Icon
10/24/2024Taylor & Morgan Wealth Management LLC30,000$0.40M0.3%N/A0.048%Search for SEC Filing on Google Icon
10/23/2024Trueblood Wealth Management LLC16,236$0.22M0.1%N/A0.026%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Perspective Therapeutics logo
Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. The company discovers, designs, and develop its initial programs candidates consists of VMT-a-NET, that is currently in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2) expressing tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta-emitting therapy; and VMT01, which is currently in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma. Perspective Therapeutics, Inc. has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Read More on Perspective Therapeutics

Today's Range

Now: $3.02
Low: $3.00
High: $3.21

50 Day Range

MA: $3.38
Low: $2.84
High: $4.01

52 Week Range

Now: $3.02
Low: $2.70
High: $19.05

Volume

491,599 shs

Average Volume

988,394 shs

Market Capitalization

$204.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of Perspective Therapeutics?

Perspective Therapeutics' top insider shareholders include:
  1. Lantheus Alpha Therapy, Llc (Major Shareholder)
  2. Robert F Williamson III (Director)
  3. Lori A Woods (Director)
  4. Johan M Spoor (CEO)
  5. Markus Puhlmann (Insider)
  6. Jonathan Robert Hunt (CFO)
  7. Heidi Henson (Director)
Learn More about top insider investors at Perspective Therapeutics.

Who are the major institutional investors of Perspective Therapeutics?

Perspective Therapeutics' top institutional investors include:
  1. Deerfield Management Company L.P. Series C — 4.35%
  2. Octagon Capital Advisors LP — 3.41%
  3. Nicholson Wealth Management Group LLC — 2.38%
  4. Affinity Asset Advisors LLC — 1.92%
  5. Millennium Management LLC — 1.92%
  6. Marshall Wace LLP — 1.19%
Learn More about top institutional investors of Perspective Therapeutics stock.

Which major investors are selling Perspective Therapeutics stock?

Within the previous quarter, CATX stock was sold by these institutional investors:
  1. Janus Henderson Group PLC
  2. Marshall Wace LLP
  3. Ameriprise Financial Inc.
  4. Schonfeld Strategic Advisors LLC
  5. Altium Capital Management LLC
  6. Sphera Funds Management LTD.
  7. Bank of America Corp DE
  8. Nuveen Asset Management LLC

Which major investors are buying Perspective Therapeutics stock?

Within the previous quarter, CATX stock was acquired by institutional investors including:
  1. Millennium Management LLC
  2. Octagon Capital Advisors LP
  3. Affinity Asset Advisors LLC
  4. Two Sigma Investments LP
  5. Velan Capital Investment Management LP
  6. Walleye Capital LLC
  7. Cubist Systematic Strategies LLC
  8. Jump Financial LLC
Within the previous year, these company insiders have bought Perspective Therapeutics stock:
  1. Lantheus Alpha Therapy, Llc (Major Shareholder)
  2. Robert F Williamson III (Director)
  3. Lori A Woods (Director)
  4. Johan M Spoor (CEO)
  5. Markus Puhlmann (Insider)
  6. Jonathan Robert Hunt (CFO)
  7. Heidi Henson (Director)
Learn More investors buying Perspective Therapeutics stock.